广发医药创新混合发起式A(017962)资产负债表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
830,338.90 |
1,110,293.95 |
1,053,337.72 |
56,855.66 |
| 存出保证金 |
176,152.87 |
68,109.30 |
9,998.17 |
7,211.04 |
| 交易性金融资产 |
111,292,849.04 |
184,134,496.96 |
37,490,715.62 |
25,486,944.59 |
| 其中：股票投资 |
109,674,974.96 |
181,107,054.05 |
36,177,557.48 |
25,079,300.10 |
| 债券投资 |
1,617,874.08 |
3,027,442.91 |
1,313,158.14 |
407,644.49 |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
- |
- |
- |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
80,421.96 |
- |
37,250.29 |
- |
| 应收申购款 |
1,186,046.16 |
4,720,496.66 |
300,564.51 |
2,109.25 |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
122,214,483.16 |
211,065,318.98 |
41,473,813.00 |
27,054,783.37 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
8.94 |
18.85 |
1,911,076.23 |
1.23 |
| 应付赎回款 |
2,129,550.60 |
16,396,371.25 |
565,565.38 |
327,942.03 |
| 应付管理人报酬 |
116,921.75 |
248,975.58 |
35,577.13 |
28,901.49 |
| 应付托管费 |
19,486.97 |
41,495.95 |
5,929.50 |
4,816.90 |
| 应付销售服务费 |
41,440.67 |
99,390.11 |
4,658.80 |
1,902.06 |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
34.77 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
301,127.48 |
366,770.74 |
43,318.76 |
75,123.10 |
| 负债合计 |
2,608,571.18 |
17,153,022.48 |
2,566,125.80 |
438,686.81 |
| 所有者权益 |
| 实收基金 |
111,537,643.44 |
163,124,838.42 |
31,026,875.00 |
28,855,699.22 |
| 未分配利润 |
8,068,268.54 |
30,787,458.08 |
7,880,812.20 |
-2,239,602.66 |
| 所有者权益合计 |
119,605,911.98 |
193,912,296.50 |
38,907,687.20 |
26,616,096.56 |
| 负债及所有者权益总计 |
122,214,483.16 |
211,065,318.98 |
41,473,813.00 |
27,054,783.37 |
微信公众号
证券之星APP
基本资料
